M. Robert Cooper

9.8k citations
140 papers · 7.3k · 4 hit papers · h-index 37

Impact in

  • Oncology top 0.5%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Screening and Detection
    • Cancer survivorship and care
    • Breast Cancer Treatment Studies

Papers in

M. Robert Cooper

139 papers receiving 6.8k citations

M. Robert Cooper's Hit Papers

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer 2003 · 925 citations
9250+14+28Years since publication250500750

Peers

M. Robert Cooper
Comparison fields: 5 of 147
  • Oncology 2.7k
  • Cancer Research 1.3k
  • Hematology 981
  • Pathology and Forensic Medicine 1.4k
  • Genetics 692
Replace Hans Jørgen Nielsen with:
Hans Jørgen Nielsen Denmark
Martin D. Abeloff United States
Thomas E. Moon United States
Michael Lishner Israel
Martin M. Oken United States
Harvinder S. Luthra United States
Diana Giannarelli Italy
Thomas C. Shea United States
Stephen R. Kaplan United States
Salomon M. Stemmer Israel
M. Robert Cooper relative to Hans Jørgen Nielsen Denmark Hans Jørgen Nielsen's profile →
Citations per field
00.5×1.7×
Hans Jørgen Nielsen · 1×
Citations per year

Countries citing papers authored by M. Robert Cooper

Since Specialization
Citations

This map shows the geographic impact of M. Robert Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Robert Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Robert Cooper more than expected).

Fields of papers citing papers by M. Robert Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Robert Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Robert Cooper. The network helps show where M. Robert Cooper may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Robert Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Robert Cooper Line = papers co-authored together M. Robert Cooper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
Hit paper breakdown →
2003925
2
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
Hit paper breakdown →
1992815
3
Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas
Hit paper breakdown →
2000639
4
Familial protein S deficiency is associated with recurrent thrombosis.
Hit paper breakdown →
1984486
5 1989275
6 2002235
7 2001209
8 1972173
9 1970157
10 1991132
11 1992123
12
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics.
199690
13 197988
14 198577
15
Pharmacokinetics of vincristine sulfate in adult cancer patients.
198177
16 199376
17 200274
18 197873
19 199871
20 199367

About M. Robert Cooper

M. Robert Cooper is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Molecular Biology and Hematology, having authored 140 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (19 papers), Lymphoma Diagnosis and Treatment (19 papers), Multiple Myeloma Research and Treatments (16 papers), Lung Cancer Treatments and Mutations (12 papers), Breast Cancer Treatment Studies (11 papers), Lung Cancer Research Studies (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (1.3k citations), Hematology (981 citations), Pathology and Forensic Medicine (1.4k citations) and Genetics (692 citations). M. Robert Cooper has collaborated with scholars based in United States, Malaysia and Switzerland. Frequent co-authors include Lawrence R. DeChatelet, Hyman B. Muss, Charles L. Spurr, Randal R. Nixon, P C Comp, Charles T. Esmon, George P. Canellos, James R. Anderson, Edward S. Henderson and B. A. Peterson. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Clinical Chemistry, Cancer Chemotherapy and Pharmacology and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact